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Abstract 
Background: Butane-2,3-diol (2,3-BD) is a fuel and platform biochemical with various industrial applications. 2,3-BD 
exists in three stereoisomeric forms: (2R,3R)-2,3-BD, meso-2,3-BD and (2S,3S)-2,3-BD. Microbial fermentative processes 
have been reported for (2R,3R)-2,3-BD and meso-2,3-BD production.
Results: The production of (2S,3S)-2,3-BD from glucose was acquired by whole cells of recombinant Escherichia coli 
coexpressing the α-acetolactate synthase and meso-butane-2,3-diol dehydrogenase of Enterobacter cloacae subsp. 
dissolvens strain SDM. An optimal biocatalyst for (2S,3S)-2,3-BD production, E. coli BL21 (pETDuet–PT7–budB–PT7–budC), 
was constructed and the bioconversion conditions were optimized. With the addition of 10 mM FeCl3 in the biocon-
version system, (2S,3S)-2,3-BD at a concentration of 2.2 g/L was obtained with a stereoisomeric purity of 95.0 % using 
the metabolically engineered strain from glucose.
Conclusions: The engineered E. coli strain is the first one that can be used in the direct production of (2S,3S)-2,3-BD 
from glucose. The results demonstrated that the method developed here would be a promising process for efficient 
(2S,3S)-2,3-BD production.
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Background
Butane-2,3-diol (2,3-BD) is a promising commodity 
biochemical that can be produced by biotechnological 
routes. It can be used as a starting material for the syn-
thesis of bulk chemicals including methylethylketone, 
gamma-butyrolactone and 1,3-butadiene [1–3]. Addi-
tionally, the heating value of 2,3-BD (27,200 J/g) is com-
parable with that of other liquid fuels, e.g., methanol 
(22,100  J/g) and ethanol (29,100  J/g). Thus, 2,3-BD can 
also be used as a liquid fuel or fuel additive [1–3]. There 
are three isomeric forms of 2,3-BD: (2R,3R)-2,3-BD, 
meso-2,3-BD and (2S,3S)-2,3-BD. Optically pure 2,3-BD 
can act as an excellent building block in asymmetric syn-
thesis of valuable chiral chemicals [1–3].
2,3-BD can be produced via chemical or biotechnologi-
cal routes [1, 4–10]. The selective production of optically 
pure 2,3-BD through chemical processes is difficult to 
control, complicated and expensive to perform. Further-
more, the optical purity of 2,3-BD produced via chemical 
processes was rather low. Biotechnological routes have 
emerged as the preferred methods for the optically pure 
2,3-BD production [1–3]. Although many microorgan-
isms could be used to efficiently produce 2,3-BD, Paeni-
bacillus polymyxa is the only native producer of optically 
pure (2R,3R)-2,3-BD [11–13]. Thus, specific strains of 
Escherichia coli, Saccharomyces cerevisiae, Enterobacter 
cloacae and Bacillus licheniformis have been engineered 
for optically pure 2,3-BD production in recent years 
[14–21]. For example, S. cerevisiae has been engineered 
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as a heterologous host for (2R,3R)-2,3-BD production 
[16]. The highest concentration of (2R,3R)-2,3-BD was 
more than 100 g/L. 73.8 g/L of meso-2,3-BD can also be 
produced using systematic metabolic engineered E. coli 
BL21/pET-RABC from glucose [17]. However, no fer-
mentative method for (2S,3S)-2,3-BD production has 
been reported.
Due to difficulties in the direct fermentative production 
of (2S,3S)-2,3-BD, biocatalysis has emerged as the only 
reported route for (2S,3S)-2,3-BD production [22–28]. 
Racemic acetoin, diacetyl or a mixture of three isomeric 
forms of 2,3-BD have been used as substrates for (2S,3S)-
2,3-BD production [22–28]. The highest published con-
centration of (2S,3S)-2,3-BD produced from the mixture 
of 2,3-BD was 2.4 g/L, with a low yield of 0.12 g/g [28]. 
With pure diacetyl as substrate and formate for cofac-
tor regeneration, 31.7  g/L (2S,3S)-2,3-BD was produced 
[23]. However, all of the above substrates were rather 
expensive. Thus, production of (2S,3S)-2,3-BD with high 
optical purity from cheap substrates, such as glucose, is 
rather desirable.
Until now, a microorganism that could directly produce 
(2S,3S)-2,3-BD from glucose through bioconversion has 
never been reported. In this work, a recombinant E. coli 
was constructed through coexpressing the α-acetolactate 
synthase (ALS) and meso-butane-2,3-diol dehydroge-
nase (meso-BDH) of E. cloacae subsp. dissolvens strain 
SDM. Then, (2S,3S)-2,3-BD was produced from glucose 
using whole cells of the recombinant E. coli. The process 
presented in this work could be a promising alternative 
for the biotechnological production of optically pure 
(2S,3S)-2,3-BD.
Results and discussion
Design of the metabolic pathway for (2S,3S)‑2,3‑BD 
from glucose
Many bacteria such as Klebsiella pneumoniae, Klebsiella 
oxytoca and E. cloacae can ferment sugars to a mixture 
of (2R,3R)-2,3-BD, meso-2,3-BD and (2S,3S)-2,3-BD [1, 
5, 29–32]. In previous studies, the mechanism of 2,3-BD 
stereoisomer formation in K. pneumoniae was identi-
fied [33, 34]. In the 2,3-BD-producing process, carbohy-
drate must first be converted to pyruvate. Then, three key 
enzymes, i.e., ALS, α-acetolactate decarboxylase (ALDC) 
and butane-2,3-diol dehydrogenase (BDH), are involved 
in 2,3-BD production from pyruvate. Two molecules of 
pyruvate are condensed to α-acetolactate by ALS. Then, 
ALDC catalyzes the decarboxylation of α-acetolactate 
to produce (3R)-acetoin. (3R)-acetoin will be reduced 
to meso-2,3-BD and (2R,3R)-2,3-BD by meso-BDH and 
(2R,3R)-BDH, respectively. α-Acetolactate is unstable 
and can also be catalyzed through nonenzymatic oxida-
tive decarboxylation to produce diacetyl. (2S,3S)-2,3-BD, 
the target product of this study, could only be produced 
by the meso-BDH-catalyzed two-step reduction of dia-
cetyl [33, 34]. Due to the low concentration of diacetyl in 
microbial fermentation, (2S,3S)-2,3-BD can only be pro-
duced at low concentration and stereoisomeric purity.
Based on the native (2S,3S)-2,3-BD producing process 
mentioned above, we designed a metabolic pathway for 
(2S,3S)-2,3-BD production from glucose by recombinant 
E. coli. Pyruvate is firstly formed from glucose via the 
endogenous Embden–Meyerhof–Parnas pathway (gly-
colysis) in E. coli. Then, α-acetolactate is produced from 
pyruvate by the exogenously expressed ALS. Diacetyl can 
be produced from α-acetolactate by nonenzymatic oxida-
tive decarboxylation. Finally, diacetyl would be reduced 
to (3S)-acetoin and then to (2S,3S)-2,3-BD by the exog-
enously expressed meso-BDH in the recombinant E. coli 
(Fig. 1).
Construction of recombinant plasmids for (2S,3S)‑2,3‑BD
In a previous report, the genes related to 2,3-BD pro-
duction in different strains were cloned into E. coli 
BL21(DE3) and the 2,3-BD synthesis abilities of the 
recombinant E. coli strains were assayed [17]. The recom-
binant E. coli expressing the genes from E. cloacae subsp. 
dissolvens SDM had the best ability to produce 2,3-BD. 
Thus, the ALS encoded by budB in E. cloacae subsp. dis-
solvens SDM was selected for the production of precur-
sors of (2S,3S)-2,3-BD (α-acetolactate and diacetyl) in 
recombinant E. coli. Additionally, besides the reduction 
of (3R)-acetoin to produce meso-2,3-BD, the meso-BDH 
encoded by budC in strain SDM could also catalyze the 
two-step reduction of diacetyl to produce (2S,3S)-2,3-BD. 
The recombinant E. coli strains expressing the meso-BDH 
have been used in the efficient production of (2S,3S)-
2,3-BD from diacetyl [23]. The highly active meso-BDH 
was also used in the (2S,3S)-2,3-BD production process.
As shown in Fig. 2, the genes encoding ALDC (acces-
sion number: 392323960), ALS (accession num-
ber: 392323961) and meso-BDH (accession number: 
392323962) are sequentially clustered in one operon and 
under control of transcriptional regulation protein AlsR 
in E. cloacae. Two separate plasmids, pETDuet–PT7–
budB–PT7–budC and pET28a–lysR–Pabc–budB–budC, 
were used for expression of the budB and budC genes of 
E. cloacae subsp. dissolvens SDM in recombinant E. coli 
(Fig. 2). In a previous report, the 2,3-BD pathway genes 
of strain SDM were expressed under the control of dif-
ferent types of promoters. The recombinant E. coli strain 
with the native promoter (Pabc) of 2,3-BD synthesis gene 
cluster of strain SDM had the best ability to produce 
2,3-BD [17]. Thus, in pET28a–lysR–Pabc–budB–budC, 
the genes lysR, budB, budC and Pabc of E. cloacae subsp. 
dissolvens SDM were ligated through gene splicing by 
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Fig. 1 Technology road map for (2S, 3S)-2,3-BD production from glucose by recombinant E. coli. ALS α-acetolactate synthase, meso-BDH meso-
butane-2,3-diol dehydrogenase, NOD non-enzymatic oxidative decarboxylation, EMP Embden–Meyerhof–Parnas pathway
Fig. 2 Construction of recombinant vectors for ALS and meso-BDH expression. a Construction of pETDuet–PT7–budB–PT7–budC. b Construction of 
pET28a–lysR–Pabc–budB–budC. lysR, the gene encoding the transcriptional regulator; budB, the gene encoding ALS; budA, the gene encoding ALDC; 
budC, the gene encoding meso-BDH, Pabc, the predicted promoter of the 2,3-BD pathway gene cluster from E. cloacae subsp. dissolvens strain SDM
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overlap extension and cloned into the multiple clone site 
of pET28a. The expression of both budB and budC was 
also under the control of transcriptional regulation pro-
tein AlsR and the promoter Pabc of the 2,3-BD pathway 
gene cluster of strain SDM (Fig.  2b). In pETDuet–PT7–
budB–PT7–budC, budB and budC were cloned into the 
two multiple clone sites of pETDuet-1 and under the 
control of the promoter PT7 (Fig. 2a).
The budB and budC genes were successfully cloned 
from E. cloacae subsp. dissolvens SDM and then inserted 
into pETDuet-1 to get pETDuet–PT7–budB–PT7–budC 
(Additional file 1: Figure S1). The fragment budB–budC 
amplified from the genomic DNA of SDM was about 
2500  bp; while the fragment lysR–Pabc amplified from 
the genomic DNA of SDM was about 1000 bp (Additio-
anl file 1: Figure S1). These two fragments were ligated 
through recombinant PCR to get fragment lysR–Pabc–
budB–budC. This fragment was inserted into pET28a 
and resulted in plasmid pET28a–lysR–Pabc–budB–budC.
Production of (2S,3S)‑2,3‑BD by different recombinant  
E. coli strains
The constructed expression vectors were transformed 
into E. coli BL21(DE3) and the 2,3-BD synthesis abilities 
of the whole cells of recombinant strains were assayed. 
The 20 mL reaction mixtures were incubated at 30 °C and 
180 rpm in a 50-mL flask.
The concentrations of glucose and whole cells of 
recombinant E. coli strains were 40 g/L and 5 g dry cell 
weight (DCW)/L, respectively. After 24 h bioconversion, 
the concentrations of 2,3-BD and glucose in the reaction 
mixture were determined. As shown in Table  1, E. coli 
BL21 (pETDuet-1) and BL21 (pET28a–lysR–Pabc–budB–
budC) could not produce (2S,3S)-2,3-BD within 24 h. E. 
coli BL21 (pETDuet–PT7–budB–PT7–budC) had a higher 
ability to produce 2,3-BD. 2,3-BD at a concentration of 
1.14  g/L was produced by E. coli BL21 (pETDuet–PT7–
budB–PT7–budC) within 24 h. The strain also showed the 
highest 2,3-BD yield among the strains harboring differ-
ent recombinant plasmids (Table 1).
The activities of ALDC, ALS, and BDH in the recom-
binant strains were also assayed (Table  2). Consistent 
with the result of 2,3-BD production, E. coli BL21 (pET-
Duet-1) exhibited low ALS and BDH activities. E. coli 
BL21 (pETDuet–PT7–budB–PT7–budC) showed the 
highest ALS and meso-BDH activities. No ALDC activ-
ity could be detected in all of the E. coli strains. Since the 
concentration of 2,3-BD obtained and the ALS and meso-
BDH activities of E. coli BL21 (pETDuet–PT7–budB–
PT7–budC) were higher than that of other recombinant 
strains, E. coli BL21 (pETDuet–PT7–budB–PT7–budC) 
was chosen for further investigation.
Effect of pH on production of (2S,3S)‑2,3‑BD 
by recombinant E. coli
The stereoisomeric composition of 2,3-BD produced 
by E. coli BL21 (pETDuet–PT7–budB–PT7–budC) was 
analyzed with GC. As shown in Fig.  3b, a mixture of 
2,3-BD was obtained, which contained only 57.4  % of 
(2S,3S)-2,3-BD. This result is rather inconsistent with our 
Table 1 Glucose consumption, product and yield analyses of E. coli strains harboring different vectors in 24 h flask cul-
tures
Data are the mean ± standard deviations (SDs) from three parallel experiments
Strain Glucose consumed (g/L) 2,3‑BD (g/L) 2,3‑BD yield (g/g)
E. coli BL21 (pETDuet-1) 12.00 ± 0.00 ND 0.00
E. coli BL21 (pET28a–lysR–Pabc–budB–budC) 14.00 ± 0.00 ND 0.00
E. coli BL21 (pETDuet–PT7–budB–PT7–budC) 13.67 ± 0.58 1.14 ± 0.01 0.08
Table 2 Enzyme activities of E. coli strains harboring different vectors in 24 h flask cultures
Data are the mean ± standard deviations (SDs) from three parallel experiments
ALS α-acetolactate synthase, ALDC α-acetolactate decarboxylase, BDH butane-2,3-diol dehydrogenase
Strain ALS activity  
(U/mg)





E. coli BL21 (pETDuet-1) 0.03 ± 0.04 ND 0.18 ± 0.01 0.20 ± 0.04 ND
E. coli BL21 (pET28a–lysR–Pabc–budB–budC) 0.16 ± 0.03 ND 1.79 ± 0.17 1.17 ± 0.09 0.38 ± 0.02
E. coli BL21 (pETDuet–PT7–budB–PT7–budC) 1.67 ± 0.06 ND 7.20 ± 1.21 4.20 ± 0.23 2.80 ± 0.20
Page 5 of 11Chu et al. Biotechnol Biofuels  (2015) 8:143 
expectation. Thus, we analyzed the bioconversion sys-
tem and drew the time course of the process. As shown 
in Fig.  3a, during the bioconversion process, pH was 
decreased from 7.0 to 5.0 due to production of organic 
acids. Thus, we expected that the decrease in pH might 
be the reason of the low stereoisomeric purity of the 
(2S,3S)-2,3-BD.
Then, during the bioconversion process, 10  M NaOH 
was added periodically to control the pH of the biocon-
version system at 7.0 (Fig. 4a). As shown in Fig. 4b, pH 
adjustment resulted in a higher (2S,3S)-2,3-BD con-
centration, yield and especially a higher stereoisomeric 
purity of (2S,3S)-2,3-BD. Consequently, pH was main-
tained at 7.0 during subsequent bioconversions.
Fig. 3 Production of 2,3-BD from glucose using whole cells of E. coli BL21 (pETDuet–PT7–budB–PT7–budC) without pH adjustment. a Time course of 
2,3-BD production from glucose using whole cells of E. coli BL21 (pETDuet–PT7–budB–PT7–budC) without pH adjustment. b Chromatograph profile 
of 2,3-BD produced from glucose using whole cells of E. coli BL21 (pETDuet–PT7–budB–PT7–budC) without pH adjustment (asterisk isoamyl alcohol 
was used as the internal standard)
Fig. 4 Production of 2,3-BD from glucose using whole cells of E. coli BL21 (pETDuet–PT7–budB–PT7–budC) with pH adjustment. a Time course of 
2,3-BD production from glucose using whole cells of E. coli BL21 (pETDuet–PT7–budB–PT7–budC) with pH adjustment. b Chromatograph profile of 
2,3-BD produced from glucose using whole cells of E. coli BL21 (pETDuet–PT7–budB–PT7–budC) with pH adjustment (asterisk isoamyl alcohol was 
used as the internal standard)
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Effect of temperature on production of (2S,3S)‑2,3‑BD 
by recombinant E. coli
Efficiency of the bioconversion processes and non-enzy-
matic reaction is temperature dependent. Thus, in this 
study, the effects of temperature (16, 25, 30, 37, 45 and 
55 °C) on (2S,3S)-2,3-BD production were also examined. 
As shown in Fig. 5, the highest (2S,3S)-2,3-BD concentra-
tion was obtained when the temperature was maintained 
at 37  °C. However, the stereoisomeric purity of (2S,3S)-
2,3-BD was much lower than that of 25 and 30  °C. The 
stereoisomeric purity of (2S,3S)-2,3-BD is rather impor-
tant for its utilization as the building block in asymmet-
ric synthesis. Since both high product concentration and 
stereoisomeric purity could be obtained at 30  °C, this 
temperature was chosen for subsequent bioconversions.
Effect of Fe3+ addition on (2S,3S)‑2,3‑BD production
To achieve higher (2S,3S)-2,3-BD concentration, non-
enzymatic oxidative decarboxylation of α-acetolactate 
should be enhanced. It was reported that conversion of 
α-acetolactate into diacetyl could be enhanced by addi-
tion of Fe3+ [35]. To study the effect of the addition of 
Fe3+ on (2S,3S)-2,3-BD production, 10  mM FeCl3 or 
10  mM ethylenediaminetetraacetic acid ferric sodium 
salt (EDTA-FeNa) was added at the beginning of the bio-
conversion process. The (2S,3S)-2,3-BD production and 
glucose consumption were detected after 24 h bioconver-
sion. As shown in Table 3, addition of FeCl3 would result 
in a higher (2S,3S)-2,3-BD yield.
Batch bioconversion under optimal conditions
Combining the results mentioned above, an optimal sys-
tem for the production of (2S,3S)-2,3-BD from glucose 
was developed. Bioconversion was conducted at 30  °C 
in 50-mL shake flasks containing 20  mL medium. The 
medium consisted of 40  g/L glucose, 10  mM FeCl3 and 
5 g DCW/L whole cells of E. coli BL21 (pETDuet–PT7–
budB–PT7–budC). The pH was maintained at 7.0 through 
periodical addition of 10 M NaOH.
As shown in Fig. 6, 2.2 g/L (2S,3S)-2,3-BD was obtained 
from 26.7  g/L glucose after 24  h of bioconversion. The 
yield of (2S,3S)-2,3-BD was at 16.1  % of the theoretical 
value (Fig. 6a). The stereoisomeric purity of the (2S,3S)-
2,3-BD produced by strain E. coli BL21 (pETDuet–
PT7–budB–PT7–budC) was 95  % (Fig.  6b). Just like the 
situation of the fermentation process, the (2S,3S)-2,3-BD 
was produced through a mixed acid pathway during the 
bioconversion process. By-products including acetate, 
lactate, formate, succinate, acetoin and ethanol were 
detected in the bioconversion system (Additional file  1: 
Figure S2). Further enhancement of (2S,3S)-2,3-BD pro-
duction might be acquired through elimination of these 
by-products through gene knockout.
Several biotechnological routes including enzymatic or 
whole-cell conversion methods have been used to produce 
(2S,3S)-2,3-BD (Table  4). Among all of the reported bio-
technological processes, Wang et  al. obtained the highest 
(2S,3S)-2,3-BD concentration of 31.7 g/L from diacetyl using 
recombinant E. coli coexpressing FDH and meso-BDH [23]. 
Efforts have also been tried to increase (2S,3S)-2,3-BD pro-
duction through biotransformation of racemic acetoin [25, 
26]. However, the prices of these two substrates, acetoin and 
diacetyl, are too high for the actual production of (2S,3S)-
2,3-BD. Using racemic 2,3-BD as the substrate, the recom-
binant E. coli strain that coexpressed (2R,3R)-2,3-BDH and 
NADH oxidase produced (2S,3S)-2,3-BD at a concentration 
of 2.4 g/L [28]. Due to the low content of (2S,3S)-2,3-BD in 
the mixture of 2,3-BD (often lower than 10 %), the yield of 
(2S,3S)-2,3-BD was rather low, which increased the real sub-
strate cost of the biocatalystic process.
Fig. 5 Effect of temperature on (2S,3S)-2,3-BD production by recom-
binant E. coli BL21 (pETDuet–PT7–budB–PT7–budC)
Table 3 Effects of Fe3+ addition on glucose consumption, 2,3-BD production, yield and purity of (2S,3S)-2,3-BD
Data are the mean ± standard deviations (SDs) from three parallel experiments
Condition Glucose consumed (g/L) 2,3‑BD (g/L) 2,3‑BD yield (g/g) Purity of (2S,3S)‑2,3‑BD
Blank 32.00 ± 1.00 1.93 ± 0.04 0.060 ± 0.001 0.84 ± 0.02
10 mM FeCl3 27.00 ± 1.00 1.73 ± 0.03 0.064 ± 0.001 0.86 ± 0.02
10 mM EDTA-FeNa 24.67 ± 1.53 0.41 ± 0.03 0.017 ± 0.001 1.00 ± 0.00
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It has been reported that the cost of substrates 
accounted for more than about 30 % of total cost of 2,3-
BD production. In this work, we constructed a recom-
binant E. coli coexpressing ALS and meso-BDH for the 
production of (2S,3S)-2,3-BD from a cheap substrate, glu-
cose. The product concentration of our system was lower 
than that of processes using other substrates (Table  4). 
However, the cost analyses indicated that our process 
could produce (2S,3S)-2,3-BD at a rather low substrate 
cost (Additional file 1: Table S1). Thus, the method pre-
sented in this work would be a promising process for 
(2S,3S)-2,3-BD production.
Conclusions
An efficient process for (2S,3S)-2,3-BD production 
from glucose was developed by using recombinant E. 
coli coexpressing ALS and meso-BDH. Under optimal 
conditions, the bioconversion process could produce 
Fig. 6 Production of 2,3-BD from glucose using whole cells of E. coli BL21 (pETDuet–PT7–budB–PT7–budC) with Fe
3+ addition. a Time course of 2,3-
BD production from glucose using whole cells of E. coli BL21 (pETDuet–PT7–budB–PT7–budC) with Fe
3+ addition. b Chromatograph profile of 2,3-BD 
produced from glucose using whole cells of E. coli BL21 (pETDuet–PT7–budB–PT7–budC) with Fe
3+ addition (asterisk isoamyl alcohol was used as the 
internal standard)
Table 4 Researches on the production of (2S,3S)-2,3-BD using varying substrates
Cost analyses of substrates were performed as described in Additional file 1
Biocatalyst Substrate (2S,3S)‑2,3‑BD (g/L) Yield (g/g) Co‑substrate Cost ($/kg) References
E. coli coexpressing formate dehydrogenase from 
Candida boidinii NCYC 1513 and meso-BDH from E. 
cloacae subsp. dissolvens SDM
Diacetyl 31.7 0.90 Formate 24.4 [23]
E. coli expressing meso-BDH from E. cloacae subsp. 
dissolvens SDM
Diacetyl 26.8 0.67 Glucose 32.8 [24]
E. coli JM109 coexpressing meso-BDH from K. pneu-
moniae and (2S,3S)-2,3-BDH from Brevibacterium 
saccharolyticum C-1012
Diacetyl 2.2 0.93 Glucose 23.7 [25]
E. coli JM109 expressing (2S,3S)-2,3-BDH from Br. sac-
charolyticum
Racemic acetoin 3.7 0.37 Glucose 85.7 [26]
E. coli expressing acetoin reductase from Rhodococ-
cus erythropolis WZ010
Diacetyl 5.3 1.03 NADH 21.4 [27]
E. coli BL21 coexpressing (2R,3R)-2,3-BDH from Bacil-
lus subtilis 168 and NADH oxidase from Lactobacil-
lus brevis CICC 6004
2,3-BD 2.4 0.12 13.3 [28]
E. coli BL21 (DE3) coexpressing ALS and meso-BDH 
from E. cloacae subsp. dissolvens SDM
Glucose 2.2 0.08 9.4 This work
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2.2  g/L (2S,3S)-2,3-BD with a yield of 0.08  g/g glu-
cose. The stereoisomeric purity of (2S,3S)-2,3-BD 
produced from glucose was 95 %. The cost analysis sug-
gests that the novel bioconversion system can serve 




(2S,3S)-2,3-BD (99.0  %), (2R,3R)-2,3-BD (98.0  %) and 
meso-2,3-BD (98.0  %) were purchased from ACROS 
(The Kingdom of Belgium). Racemic acetoin (99.0  %) 
was purchased from Apple Flavor & Fragrance Group 
Co. (Shanghai, China). Diacetyl, ampicillin, isopropyl-β-
d-thiogalactoside (IPTG), reduced nicotinamide adenine 
dinucleotide (NADH) and nicotinamide adenine dinu-
cleotide (NAD) were purchased from Sigma. PCR prim-
ers were prepared by Sangon (Shanghai, China). Fast 
Pfu DNA polymerase was purchased from TransGen 
Biotech (Beijing, China). T4 DNA ligase and restriction 
endonucleases were obtained from Fermentas (Lithu-
ania). All other chemicals were of analytical grade and 
commercially available.
Bacterial strains and plasmids
The bacterial strains and plasmids used in this study are 
listed in Table 5. E. coli DH5α and BL21 (DE3) were used 
as cloning and expression host, respectively. The pEASY-
Blunt cloning vector (TransGen Biotech, China) was 
used for gene cloning, pETDuet-1 and pET28a were used 
for gene expression. E. cloacae strain SDM was cultured 
in a medium containing the following (g/L) at pH 7.0: 
glucose, 15; peptone, 10; yeast extract, 5; KCl, 5. Luria–
Bertani (LB) medium was used for E. coli cultivations. 
Ampicillin was used at a concentration of 100 μg/mL and 
kanamycin was used at a concentration of 50 μg/mL.
Construction of plasmid pETDuet–PT7–budB–PT7–budC
E. cloacae strain SDM genomic DNAs were extracted 
with the Wizard Genomic DNA Purification Kit (Pro-
mega, Madison, WI, USA). The budB gene was ampli-
fied by PCR using forward primer budB-F with a BglII 
restriction site insertion and reverse primer budB-R with 
a XhoI restriction site insertion (Table 5). The PCR prod-
uct was firstly ligated to the pEASY-Blunt vector, and the 
resulting plasmid was designated pEASY-Blunt–budB. 
Next, pEASY-Blunt–budB was digested with BglII and 
Table 5 Bacterial strains, plasmids and primers used in this study
Name Characteristic References
Strains
 E. coli DH5α F− ϕ80 lacZΔM15 Δ(lacZYA-argF)U169 recA1 endA1 hsdR17(rk−, mk+) supE44λ-thi-1 Novagen
 E. coli BL21(DE3) F− ompT gal dcm lon hsdSB(rB
−mB
−) λ(DE3) Novagen
 E. cloacae subsp. dissolvens SDM Wild type [5]
 E. coli BL21 (pET28a–lysR–Pabc–budB–
budC)
E. coli BL21(DE3) harboring pET28a–lysR–Pabc–budB–budC This study
 E. coli BL21 (pETDuet–PT7–budB–PT7–
budC)
E. coli BL21(DE3) harboring pETDuet–PT7–budB–PT7–budC This study
Plasmids
 pET28a Expression vector, Kanr Novagen
 pETDute-1 Expression vector, Ampr Novagen
 pEasy-Blunt Kanr Ampr oripUC Transgen
 pET28a–lysR–Pabc–budB–budC lysR, Pabc, budB and budC of E. cloacae subsp. dissolvens SDM were ligated and cloned into 
the multiple clone site of pET28a
This study
 pETDuet–PT7–budB–PT7–budC budB and budC from Enterobacter cloacae subsp. dissolvens SDM were cloned into the two 
multiple clone sites of pETDuet-1
This study
Primers
 budB-F (BglII) 5′-AGATCTAGTGAACAGTGATAAACAG-3′ This study
 budB-R (XhoI) 5′-CTCGAGTCACAAAATCTGGCTGAGA-3′ This study
 budC-F (EcoRI) 5′-GAATTCAATGCAAAAAGTTGCTCTCG-3′ This study
 budC-R (HindIII) 5′-AAGCTTTTAATTGAATACCATCCCACCGT-3′ This study
 lysR–Pabc-F (BglII) 5′-CGGTAGATCTCTACTCCTCGCTTATCATCG-3′ This study
 lysR–Pabc-R 5′-CTCACTGTTCATGCTCGTCCTCTTC-3′ This study
 budB–budC-F 5′-GAAGAGGACGAGCATGAACAGTGAG-3′ This study
 budB–budC-R (HindIII) 5′-GCCTAAGCTTTTAGTTGAACACCATCCCA-3′ This study
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XhoI, and the gel-purified budB fragment was ligated to 
the pETDuet-1 vector digested with the same restriction 
enzymes. The resulting plasmid was designated pET-
Duet–PT7–budB. Using the same process as described 
above, the budC gene fragment was obtained from the 
genome of E. cloacae strain SDM using primers budC-
F (with the EcoRI restriction site) and budC-R (with the 
HindIII restriction site) (Table  5), and the pETDuet–
PT7–budB–PT7–budC was constructed based on the 
pETDuet–PT7–budB.
Construction of plasmid pET28a–lysR–Pabc–budB–budC
The lysR, Pabc, budB and budC are sequentially clus-
tered in one operon in the E. cloacae SDM. The frag-
ments lysR–Pabc and budB–budC of E. cloacae SDM 
were amplified through PCR with the primer pairs lysR–
Pabc-F(BglII)/lysR–Pabc-R(overlap) and budB–budC-
F(overlap)/budB–budC-R(HindIII), respectively. Then 
the fragments lysR–Pabc and budB–budC of E. cloacae 
SDM were then ligated through gene splicing by over-
lap extension using the primers lysR–Pabc-F(BglII) and 
budB–budC-R(HindIII). Then fragment lysR–Pabc–
budB–budC was ligated to the pEASY-Blunt vector to 
get pEASY-Blunt–lysR–Pabc–budB–budC. Then, pEASY-
Blunt–lysR–Pabc–budB–budC was digested with BglII 
and HindIII, and the gel-purified lysR–Pabc–budB–budC 
fragment was ligated to the pET28a vector digested with 
the same restriction enzymes. The resulting plasmid was 
designated pET28a–lysR–Pabc–budB–budC.
Biocatalyst preparation and bioconversion conditions
LB medium supplemented with 100 μg/mL ampicillin or 
50 μg/mL kanamycin was used to cultivate E. coli BL21 
(pETDuet-1) and E. coli BL21 (pET28a–lysR–Pabc–budB–
budC). The cells of the strains were grown for 12 h, then 
centrifuged at 13,000×g for 5 min, and washed twice with 
67 mM phosphate buffer (pH 7.4). The E. coli BL21 (pET-
Duet–PT7–budB–PT7–budC) were grown in LB medium 
containing 100 μg/mL of ampicillin at 37 °C on a rotary 
shaker (180 rpm). The cultures were induced with 1 mM 
IPTG at an OD620 nm of 0.6 at 16 °C for about 10 h. The 
cells were harvested by centrifugation at 6000×g for 
5 min at 4 °C and then washed twice with 67 mM phos-
phate buffer (pH 7.4). The cell pellets were resuspended 
in 67  mM phosphate buffer (pH 7.4) as biocatalysts for 
further bioconversion study.
(2S,3S)-2,3-BD production was carried out using 
40.0  g/L of glucose as the substrate and 5.0  g DCW/L 
whole cells of the recombinant as the biocatalysts. 20 mL 
of mixture with 10  mM Fe3+ was reacted at 30  °C and 
180 rpm in 50 mL flasks. pH was controlled at 7.0 by add-
ing 10 M NaOH.
Enzyme activity assays
To measure enzyme activity, the cells of the different E. 
coli strains were resuspended in 67 mM phosphate buffer 
(pH 7.4) and disrupted with an ultrasonic cell-break-
ing apparatus (Xinzhi, Ningbo, China). Cell debris was 
removed through centrifugation at 13,000×g for 15 min. 
The resulting supernatants were used in the successive 
enzyme activity assays. All enzyme assays were per-
formed at 30 °C with the proper enzyme in 67 mM phos-
phate buffer (pH 7.4).
Activity of ALS was measured by monitoring the con-
version of pyruvate to α-acetolactate [36]. One unit of 
ALS activity was defined as the amount of enzyme that 
produced 1 μmol of α-acetolactate per minute.
ALDC activity was assayed by detecting the production 
of acetoin from α-acetolactate [37]. α-Acetolactate was pre-
pared immediately before use of ethyl 2-acetoxy-2-methyl-
acetoacetate, according to the protocol supplied by the 
manufacturer. One unit of ALDC activity was defined as the 
amount of protein that formed 1 μmol of acetoin per min.
meso-BDH activity was assayed by measuring the 
change in absorbance at 340  nm corresponding to the 
oxidation of NADH or reduction of NAD when diacetyl 
or acetoin was used as the substrate [38]. For the reduc-
tion reaction, 5  mM acetoin or diacetyl and 0.2  mM 
NADH were used for the enzyme assay, and 10  mM 
meso-2,3-BD and 1 mM NAD were used for the oxidation 
reactions. One unit of enzyme activity was defined as the 
amount of enzyme that consumed 1 μmol of NADH or 
produced 1 μmol of NADH per minute.
The protein concentration was determined by the 
Lowry procedure using bovine serum albumin as the 
standard [39].
Analytical methods
Samples were withdrawn periodically and centrifuged at 
12,000×g for 10  min. The concentration of glucose was 
measured enzymatically by a bio-analyzer (SBA-40D, 
Shandong Academy of Sciences, China) after diluting to an 
appropriate concentration. The concentrations of 2,3-BD 
were analyzed by GC (Varian 3800) as described previously 
[17]. The GC system was equipped with a capillary GC col-
umn (AT. SE-54, inside diameter, 0.32 mm; length, 30 m, 
Chromatographic Technology Center, Lanzhou Institute 
of Chemical Physics, China). The ratio of the three stere-
oisomers of 2,3-BD was analyzed by GC (Agilent GC6820) 
using a fused silica capillary column (Supelco Beta 
DEXTM 120, inside diameter 0.25 mm; length 30 m) [40]. 
The stereoisomeric purity of (2S,3S)-2,3-BD was defined 
as (([S])/([M] +  [S] +  [R])) × 100 %, where [S], [M] and 
[R] represent the concentrations of (2S,3S)-2,3-BD, meso-
2,3-BD and (2R,3R)-2,3-BD, respectively.
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